Sun Young Rha

34.6k total citations · 5 hit papers
710 papers, 17.9k citations indexed

About

Sun Young Rha is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sun Young Rha has authored 710 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 396 papers in Pulmonary and Respiratory Medicine, 377 papers in Oncology and 214 papers in Molecular Biology. Recurrent topics in Sun Young Rha's work include Gastric Cancer Management and Outcomes (199 papers), Colorectal Cancer Treatments and Studies (115 papers) and Renal cell carcinoma treatment (101 papers). Sun Young Rha is often cited by papers focused on Gastric Cancer Management and Outcomes (199 papers), Colorectal Cancer Treatments and Studies (115 papers) and Renal cell carcinoma treatment (101 papers). Sun Young Rha collaborates with scholars based in South Korea, United States and Japan. Sun Young Rha's co-authors include Hyun Cheol Chung, Hei‐Cheul Jeung, Sung Hoon Noh, Joong Bae Ahn, Jae Kyung Roh, Hyo Song Kim, Toni K. Choueiri, Lori Wood, Frede Donskov and Brian I. Rini and has published in prestigious journals such as The Lancet, Nature Medicine and Nature Communications.

In The Last Decade

Sun Young Rha

680 papers receiving 17.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

2011 845 citations Sun Young Rha, Sook Ryun Park et al. Journal of Clinical Oncology profile →
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

2013 730 citations Sun Young Rha et al. profile →
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

2016 539 citations Antoîne Italiano, Sun Young Rha et al. profile →
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

2023 213 citations Yuxian Bai, Sara Lonardi et al. profile →
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study

2024 43 citations Bob T. Li, Funda Meric‐Bernstam et al. profile →

Peers

Countries citing papers authored by Sun Young Rha

Since Specialization

Citations

This map shows the geographic impact of Sun Young Rha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Young Rha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Young Rha more than expected).

Fields of papers citing papers by Sun Young Rha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sun Young Rha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Young Rha. The network helps show where Sun Young Rha may publish in the future.

Co-authorship network of co-authors of Sun Young Rha

This figure shows the co-authorship network connecting the top 25 collaborators of Sun Young Rha. A scholar is included among the top collaborators of Sun Young Rha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sun Young Rha. Sun Young Rha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LBA10 Bemarituzumab (BEMA) plus chemotherapy for advanced or metastatic FGFR2b-overexpressing gastric or gastroesophageal junction cancer (G/GEJC): FORTITUDE-101 phase III study results 2025 ·Annals of Oncology ·Sun Young Rha, (unknown), Ana Fernández Montés, Shu Qin, (unknown), Anneli Elme, Hacı Mehmet Türk, Carmelo Pozzo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Savneet Kaur, Kei Muro, (unknown)	0
2	1401O Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03) 2024 ·Annals of Oncology ·Y. Y. Janjigian, Hanneke W.M. van Laarhoven, Sun Young Rha, (unknown), D-Y. Oh, (unknown), (unknown), (unknown), (unknown), (unknown), Hugo Ford, Maxime Chénard-Poirier, Saeed Raoufmoghaddam, (unknown), Chi Zhang, (unknown), Jae Man Lee	11
3	44P BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy 2024 ·Annals of Oncology ·Grainne M. O’Kane, Jennifer L. Spratlin, D-Y. Oh, Sun Young Rha, Elaine McWhirter, (unknown), Petr Kavan, (unknown), (unknown), Rachel Goodwin, J. Randolph Hecht, (unknown), (unknown), (unknown), Michelle Jones, (unknown), (unknown), Gonzalo Spera, (unknown)	1
4	Identifying Anti-cancer Effects and Exploring the Mechanism of an MPS1/TTK Inhibitor in Gastric Cancer 2024 ·Cancer Research and Treatment ·(unknown), Woo Sun Kwon, Tae Soo Kim, (unknown), Sung‐Hwan Kim, Sun Young Rha	1
5	LBA3 Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancer 2024 ·Annals of Oncology ·Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, Takashi Oshima, Nina Karaseva, M. A. Osipov, (unknown), Hiroshi Yabusaki, S. G. Afanasyev, Park Yk, S-E. Al-Batran, Takaki Yoshikawa, (unknown), Maria Di Bartolomeo, Sara Lonardi, (unknown), (unknown), (unknown), Y-J. Bang	7
6	Neoadjuvant/adjuvant pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585. 2024 ·Journal of Clinical Oncology ·Kohei Shitara, Yung‐Jue Bang, Lucjan Wyrwicz, Sun Young Rha, Takashi Oshima, Maria Di Bartolomeo, Young Kyu Park, Sara Lonardi, (unknown), Chia‐Jui Yen, Jean‐Philippe Metges, Marcelo Garrido, Markus Moehler, (unknown), Wei Peng Yong, Andrea Spallanzani, Erin Jensen, (unknown), Chie‐Schin Shih, Salah-Eddin Al-Batran	2
7	A randomized, multicenter, open-label, phase 2 study of TRK-950 in combination with ramucirumab and paclitaxel as second-line therapy in patients with Caprin-1 positive gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. 2024 ·Journal of Clinical Oncology ·Ronan J. Kelly, (unknown), Kensei Yamaguchi, (unknown), Toshihiro Kudo, Zev A. Wainberg, Sun Young Rha, Jeeyun Lee, Min‐Hee Ryu, (unknown), Kohei Shitara	2
8	Pembrolizumab (pembro) + chemotherapy (chemo) for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Updated results from the KEYNOTE-859 study. 2024 ·Journal of Clinical Oncology ·Sun Young Rha, Lucjan Wyrwicz, (unknown), Yuxian Bai, Min‐Hee Ryu, Jeeyun Lee, Fernando Rivera, Gustavo Vasconcelos Alves, Marcelo Garrido, Kai‐Keen Shiu, M. Fernández, Jin Li, Maeve A. Lowery, Timuçin Çil, Felipe José Silva Melo Cruz, Do‐Youn Oh, Lina Yin, Sonal Bordia, Pooja Bhagia, Shukui Qin	5
9	821TiP Phase I study of ceralasertib (cerala) in combination with AZD5305 in patients (pts) with advanced/metastatic ovarian cancer (OC) previously treated with PARP inhibitors (PARPis) 2023 ·Annals of Oncology ·Geoffrey I. Shapiro, Bristi Basu, Anthony B. El-Khoueiry, Sophie Postel‐Vinay, S-A. Im, Sun Young Rha, Claire F. Friedman, Antoîne Italiano, Young Mo Kim, (unknown), René L. Roux, (unknown), Michelle Brown, B. Webb, Natalia Lukashchuk, Emma Dean, (unknown), (unknown), Matthew Krebs	2
10	Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study 2023 ·Gastric Cancer ·Choong‐kun Lee, Jii Bum Lee, Se Jin Park, Jingmin Che, Woo Sun Kwon, Hyo Song Kim, Minkyu Jung, (unknown), Sook Ryun Park, Dong‐Hoe Koo, Hyun Woo Lee, Woo Kyun Bae, Hei‐Cheul Jeung, In Gyu Hwang, Hyunki Kim, Chung Mo Nam, Hyun Cheol Chung, Sun Young Rha	10
11	O-3 Additional data from the KEYNOTE-859 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer 2023 ·Annals of Oncology ·Lucjan Wyrwicz, Do‐Youn Oh, (unknown), Yuxian Bai, Min‐Hee Ryu, (unknown), Fernando Rivera, Gustavo Vasconcelos Alves, Marcelo Garrido, Kai‐Keen Shiu, (unknown), J. Li, (unknown), (unknown), (unknown), Shukui Qin, Lei Yin, Sonal Bordia, Pooja Bhagia, Sun Young Rha	3
12	1315MO Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC) 2023 ·Annals of Oncology ·Alison M. Schram, Kōichi Goto, Dongwook Kim, Antoine Hollebecque, Sun Young Rha, Kazumi Nishino, M. Duruisseaux, (unknown), Joon Oh Park, Natasha B. Leighl, Teresa Macarulla, Stephen V. Liu, Mohammed Najeeb Al Hallak, James M. Cleary, Cindy Neuzillet, Yasushi Goto, Andrew K. Joe, (unknown), (unknown), Alexander Drilon	10
13	1883MO MEDI5752 (volrustomig), a novel PD-1/CTLA-4 bispecific antibody, in the first-line (1L) treatment of 65 patients (pts) with advanced clear cell renal cell carcinoma (aRCC) 2023 ·Annals of Oncology ·Martin H. Voss, Benjamin Garmezy, (unknown), J.P. Maroto Rey, André Mansinho, Alejo Rodríguez‐Vida, Júlio Oliveira, Martien van Dongen, (unknown), Sylvie Négrier, Ben Tran, Benedito A. Carneiro, (unknown), Sun Young Rha, Yan Wang, Shelby D. Gainer, Zhiyuan Tang, Ikbel Achour, (unknown), Laurence Albigès	7
14	654O Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with solid tumors harboring specific HER2-activating mutations (HER2m): Primary results from the international phase II DESTINY-PanTumor01 (DPT-01) study 2023 ·Annals of Oncology ·Bob T. Li, Funda Meric‐Bernstam, Aditya Bardia, Yoichi Naito, Salvatore Siena, Philippe Aftimos, Ian C. Anderson, Giuseppe Curigliano, Maria J. de Miguel, Mamta Kalra, D-Y. Oh, (unknown), Sophie Postel‐Vinay, Sun Young Rha, Taroh Satoh, Iben Spanggaard, Flavia Michelini, Aaron Smith, (unknown), C. Saura Manich	19
15	Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Choong‐kun Lee, Soon Sung Kwon, Woo Sun Kwon, Sejung Park, Seung‐Tae Lee, Jong Rak Choi, Sun Young Rha, Saeam Shin	5
16	Upregulated, 7q21–22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer 2015 ·Cellular Signalling ·(unknown), (unknown), (unknown), Ming Hui Lee, Sun Young Rha, Patrick Tan, Kumaresan Ganesan	11
17	The Effect of Disintegrin–Metalloproteinase ADAM9 in Gastric Cancer Progression 2014 ·Molecular Cancer Therapeutics ·Jeong‐Min Kim, Hei‐Cheul Jeung, Sun Young Rha, Eun‐Jeong Yu, Tae Soo Kim, (unknown), Xianglan Zhang, Kyu-Hyun Park, Seung Woo Park, Hyun Cheol Chung, Garth Powis	40
18	Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer 2011 ·Clinical Cancer Research ·(unknown), (unknown), Kakoli Das, Chia-Huey Ooi, Niantao Deng, (unknown), Emmanuel Beillard, Julian Lee, Kalpana Ramnarayanan, Sun Young Rha, Nallasivam Palanisamy, P. Mathijs Voorhoeve, Patrick Tan	172
19	Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A , a Novel β-Catenin/TCF Target Gene 2008 ·Cancer Research ·Kumaresan Ganesan, Tatiana Ivanova, Yonghui Wu, Vikneswari Rajasegaran, Jeanie Wu, Ming Hui Lee, Kun Yu, Sun Young Rha, Hyun Cheol Chung, Bauke Ylstra, Gerrit A. Meijer, (unknown), Heike I. Grabsch, Patrick Tan	88
20	Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression 2006 ·Clinical Cancer Research ·Jangsoon Lee, Soon Young Park, Eun Kyung Lee, Chang Gyo Park, Hyun Cheol Chung, Sun Young Rha, Yong Kee Kim, Gyu‐Un Bae, (unknown), Jeung-Whan Han, Hoi Young Lee	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact